Carolyn Wasserheit-Leiblich

Statistics

Publications

Citations

164

H-Index

Active since

2008

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Carolyn Wasserheit-Leiblich is an author at Memorial Sloan Kettering Cancer Center specializing in breast cancer pharmacotherapy, pharmacology, and medicine.

Publications per year

2008–2014

Publications

A Phase II Open-Label Study of Ganetespib, a Novel Heat Shock Protein 90 Inhibitor for Patients With Metastatic Breast Cancer

Komal Jhaveri, Sarat Chandarlapaty, Diana Lake et al. · Clinical Breast Cancer · 2014 · 102 citations

Medicine, Oncology, Pharmacology +11

The Safety of Dose-Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Trastuzumab in HER-2/<i>neu</i> Overexpressed/Amplified Breast Cancer

Chau T. Dang, Monica Fornier, Steven Sugarman et al. · Journal of Clinical Oncology · 2008 · 62 citations · Full text

Medicine, Oncology, Pharmacology +13

1–2 of 2